Hologic, Inc. (HOLX) Interest Coverage Ratio: 16.73x
The interest coverage ratio for Hologic, Inc. (HOLX) is 16.73x as of Wednesday, June 10, 2026.
HOLX Interest Coverage Ratio Metrics
INTEREST COVERAGE RATIO
16.73x
HOLX Competitors' Interest Coverage Ratio
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Hologic, Inc. (HOLX) | $16.97B | 16.73x | N/A | N/A | N/A |
| Moderna, Inc. (MRNA) | $18.40B | N/A | 531.75x | 531.75x | 531.75x |
| Align Technology, Inc. (ALGN) | $12.56B | N/A | 67.41x | 66.08x | 407.22x |
| BioNTech SE (BNTX) | $21.81B | -45.74x | 444.02x | 1201.03x | 1201.03x |
| Mettler-Toledo International Inc. (MTD) | $22.85B | 16.32x | 15.71x | 16.43x | 18.17x |
| Baxter International Inc. (BAX) | $10.49B | -1.06x | 0.71x | 2.65x | 6.89x |
| Waters Corporation (WAT) | $23.83B | 17.59x | 13.40x | 13.24x | 14.07x |
| Charles River Laboratories International, Inc. (CRL) | $9.06B | 4.74x | 3.27x | 5.51x | 5.84x |
| Bio-Rad Laboratories, Inc. (BIO) | $7.89B | 5.52x | 5.51x | 7.63x | 62.06x |
| Veeva Systems Inc. (VEEV) | $26.73B | N/A | N/A | N/A | N/A |
Financial Health Indicators
Interest Coverage
16.7x
Debt/Equity
0.52
Current Ratio
3.75
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
- < 1.5x: EBIT is less than 1.5 times interest expense
- 1.5x - 3x: EBIT is between 1.5 and 3 times interest expense
- 3x - 5x: EBIT is between 3 and 5 times interest expense
- > 5x: EBIT is more than 5 times interest expense
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Hologic, Inc. Interest Coverage Ratio Formula & Definition
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Hologic, Inc. Interest Coverage Ratio FAQ
- What is the interest coverage ratio for Hologic, Inc. (HOLX)?
- The interest coverage ratio for HOLX stock is 16.73x.
About Hologic, Inc.
Hologic, Inc. is a medical technology company focused on designing, producing, and marketing a diverse range of diagnostic tests, medical imaging systems, and surgical solutions. Its core mission is to enhance women's health through proactive detection and effective treatment, serving patients in the United States, across Europe, the Asia-Pacific region, and various other international markets. The company operates through four distinct business units: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. Within its Diagnostics segment, Hologic provides Aptima molecular diagnostic assays for identifying infectious microorganisms, alongside Aptima viral load tests for conditions like HIV, Hepatitis C, and Hepatitis B. It also offers Aptima and Panther Fusion SARS-CoV-2 assays for detecting the virus, the ThinPrep System for cytology applications, and the Rapid Fetal Fibronectin Test to help clinicians assess the likelihood of premature birth. Furthermore, the company supplies various diagnostic tests for Group B Streptococcus. The Breast Health division delivers advanced imaging and analytical solutions, including 2D and 3D digital mammography systems with accompanying reading workstations. This segment also features minimally invasive breast biopsy guidance systems and devices, products for marking and localizing breast biopsy sites, specimen radiology tools, ultrasound solutions, connectivity options, and products supporting breast-conserving surgical procedures. For GYN Surgical needs, Hologic offers the NovaSure Endometrial Ablation System, designed to manage abnormal uterine bleeding, and the MyoSure Hysteroscopic Tissue Removal System for the excision of uterine fibroids, polyps, and other pathologies. Additionally, the Fluent Fluid Management System facilitates liquid distention during diagnostic and operative hysteroscopic interventions. The Skeletal Health segment includes the Horizon DXA, a dual-energy X-ray system, and the Fluoroscan Insight FD mini C-arm, which is utilized for minimally invasive orthopedic surgical procedures. Hologic distributes its comprehensive product portfolio through a combination of its dedicated direct sales and service teams, as well as via independent distributors and sales representatives. Established in 1985, Hologic, Inc. maintains its corporate headquarters in Marlborough, Massachusetts.
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Paul Malenchini